Coherus BioSciences Inc at Bank of America Global Research Healthcare Conference (Virtual) Transcript
Good day, everybody. Thanks for joining us to the Bank of America Annual Health Care Conference. My name is Jason Gerberry. I'm one of the biopharma analysts at BofA, and I'm pleased to be introducing our next company presenter, Coherus and CEO, Denny Lanfear. So Denny, first off, thanks for joining us today.
Nice to see you guys again. Thanks for the invitation. Sorry for the technical.
Questions & Answers
Yes. No, it's only a few minutes delayed, but hopefully, we can send all our questions in. So maybe the first question I want to ask you is more -- how do you think the market should think about your strategy going forward in lieu of the in-license of toripalimab anti-PD-1 brand? And do you feel like it's a fundamental pivot in the company strategy to have a
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
